Posted on Feb 1, 2019 by Bristol-Myers Squibb Company
Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.
We are seeking a highly motivated Research Scientist to be part of the Translational IHC & Histology Group in Translational Pathology. Members of this team work on various projects in concert with Discovery, Translational Research, Biomarker, Pathology and Pharmacodiagnostics for further development of the BMS Oncology/Immuno-Oncology and other therapeutic area pipelines, contributing to target discovery, lead selection, safety assessment, clinical biomarker validation, and indication selection for BMS clinical trials. The successful candidate will be responsible for developing and validating monoplex and multiplex IHC assays, in situ hybridization, and image analysis. She/he will work closely with discovery and translational research scientists, clinical biomarker leads, image analysts and pathologists to develop assays, perform tissue cross-reactivity study and disease profiling, and will document assay performance in support of their translation to clinical samples. The candidate will also be responsible for recommending and implementing novel/improved IHC technologies and technology transfer to CROs, as well as laser capture microdissection and other bioanalytical assays as needed to support Translational Research. She/he is expected to be well-versed with current GLP and GCLP expectations and the trends in multiplex IHC, as well as to contribute to presentation and publication of scientific findings.
- BS required and MS preferred with 8 years of relevant experience in life Science discipline. Applicants from academics and industry will be considered. Preference will be given to individuals with previous experience working in the fields of oncology and immuno-oncology and working in a GLP or GCLP environment.
- Proven technical expertise in developing and implementing manual or automated immunohistochemistry and in situ hybridization assays. Experience in image analysis, multiplex immunohistochemistry, and laser capture microdissection are highly desirable.
- Must be organized and able to work well in a team setting, as well as to work independently and effectively collaborate with cross-functional teams.
- Proactive at keeping current with literature and leveraging modern technologies.
- Excellent communication skills, both written and verbal are required.
NYU Langone Health
MD Anderson Cancer Center